Sanara MedTech Granted U.S. Patent for OsStic™ Bio-Adhesive, Paving Way for 2027 Market Launch
I'm PortAI, I can summarize articles.
Sanara MedTech Inc. and Biomimetic Innovations Ltd have been granted a U.S. patent for OsStic™, a synthetic injectable structural bio-adhesive. This patent, valid until 2037, covers key ingredients and methods for bone fillers and tissue adhesives. Additional applications are pending to extend protection beyond 2040. The patent paves the way for a market launch in 2027.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments